HVTN 703/HPTN 081 (AMP)
Current StudyA Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in sub-Saharan Africa Sponsors: Division of AIDS (DAIDS) National Institute of Allergy and Infect …
HPTN
More about this study »HPTN 082
Current StudyEvaluation of Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study Sponsors: Division of AIDS (DAIDS) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Mental health (NIMH) Nationa …
HPTN
More about this study »HPTN 084
Current StudyStudy Title: A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women. Protocol summary: HPTN 084 (The LIFE Study) is a study being done …
HPTN
More about this study »HIVNET/HPTN 016A
Completed StudyCondom Promotion and Counseling Sponsor: US National Institutes of Health (NIH) Protocol Summary: The aim of the study was to evaluate the effectiveness of condom promotion and counseling messages on uptake of condoms as a means to prevent HIV transmis …
HPTN
More about this study »HIVNET/HPTN 016A Substudy
Completed StudyAssociation of Sexually Transmitted Infections and HIV Among Women Attending the Condom Promotion and Counseling Study in Harare Sponsor: US National Institutes of Health (NIH) Protocol Summary: The aim of this substudy was to compare the prevalence of …
HPTN
More about this study »HIVNET/HPTN 023
Completed StudySafety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants from Birth to 6 Months Sponsor: US National Institutes of Health (NIH) Protocol Summary: HIVNET 023 was a phase I/II, open-label, …
HPTN
More about this study »HPTN 039
Completed StudyA Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High Risk HSV-2 Seropositive, HIV Seronegative Individuals Sponsors: Division of AIDS, US National Institute of Allergy and Infectio …
HPTN
More about this study »HPTN 043
Completed StudyA Phase III, Randomized, Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Post-Testing Support for HIV in Sub-Saharan Africa and Thailand (Project Accept) Sponsor: US National Institute of Mental Health Protocol Summary …
HPTN
More about this study »HPTN 052
Completed StudyA Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples Sponsors: Division of AIDS, US National Institute of Al …
HPTN
More about this study »HPTN 076
Completed StudyPhase II Safety and Acceptability of an Investigational Injectable Product, TMC278 LA, for Pre Exposure Prophylaxis (PrEP) Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID) US National Institutes of Health (NI …
HPTN
More about this study »
